Table 3.
Sociodemographic profile, baseline medication adherence, number of prescribed medication and family history of early CVD among subjects enrolled for secondary prevention of CVDs
| S.No | Variable | Intervention group (n = 250) | Comparison Group (n = 250) | Total N-500 | X2 | P value |
|---|---|---|---|---|---|---|
| 1. | Sex | |||||
| Male | 210 (84) | 205 (82) | 415 (83) | 0.35 | 0.55 | |
| Female | 40 (16) | 45 (18) | 85 (17) | |||
| 2. | Age | |||||
| 30–39 | 8 (3.2) | 7 (2.8) | 15 (3) | |||
| 40–49 | 40 (16) | 32 (12.8) | 72 (14.4) | 2.38 | 0.66 | |
| 50–59 | 80 (32) | 80 (32) | 160 (32) | |||
| 60–69 | 86 (34.4) | 100 (40) | 186 (37.2) | |||
| ≥ 70 | 36 (14.4) | 31 (12.4) | 67 (13.4) | |||
| 3. | Marital Status | |||||
| Never married | 0 | 1 (0.4) | 1 (0.2) | 3.05 | 0.38 | |
| Currently married | 228 (91.2) | 224 (89.6) | 452 (90.4) | |||
| Separated | 0 | 2 (0.8) | 2 (0.4) | |||
| Widowed | 22 (8.8) | 23 (9.2) | 45 (9) | |||
| 4. | Family Type | |||||
| Nuclear | 103 (41.2) | 96 (38.4) | 199 (39.8) | 0.79 | 0.67 | |
| Joint | 145 (58) | 153 (61.2) | 298 (59.6) | |||
| Others | 2 (0.8) | 1 (0.4) | 3 (0.6) | |||
| 5. | Socioeconomic class (Kuppuswamy) | |||||
| Upper (I) | 6 (2.4) | 12 (4.8) | 18 (3.6) | |||
| Upper Middle (II) | 101 (40.4) | 111 (44.4) | 212 (42.4) | 3.99 | 0.40 | |
| Lower middle (III) | 71 (28.4) | 68 (27.2) | 139 (27.8) | |||
| Upper Lower (IV) | 70 (28.0) | 58 (23.2) | 128 (25.6) | |||
| Lower (V) | 2 (0.8) | 1 (0.4) | 3 (0.6) | |||
| 6. | Medication adherence | |||||
| Low | 102 (40.8) | 104 (41.6) | 206 (41.2) | 0.24 | ||
| Medium | 69 (27.6) | 72 (28.8) | 141 (28.2) | 0.88 | ||
| High | 79 (31.6) | 74 (29.6) | 153 (30.6) | |||
| 7. | Number of prescribed Medication | |||||
| 1 | 0 | 3 (1.2) | 3 (0.6) | 3.15 | ||
| 2–3 | 102 (40.8) | 99 (39.6) | 201 (40.2) | 0.36 | ||
| 4–5 | 125 (50) | 127 (50.8) | 252 (50.4) | |||
| >5 | 23 (9.2) | 21 (8.4) | 44 (8.8) | |||
| 8. | Family h/o early CVD | |||||
| Yes | 74 (29.6) | 66 (26.4) | 140 (28) | 0.63 | ||
| No | 176 (70.4) | 184 (73.6) | 360 (72) | 0.42 | ||
| 9. | Duration of treatment | |||||
| <5 years | 201 (80.4) | 191 (76.4) | 392 (78.4) | 1.99 | ||
| 5–10 years | 34 (13.6) | 36 (14.4) | 70 (14) | 0.36 | ||
| >10 years. | 15 (6) | 23 (9.2) | 38 (7.6) | |||
Figures in parentheses are percentages